A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Clinical trial NCT04541810 · COMPLETED

Trial details

NCT number: NCT04541810
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)

Start date: 2021-01-26
Primary completion: 2025-12-31
Enrollment: 2369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.